Evaluation of Soft Tissue Response to Titanium Healing Abutments Treated by Erbium: YAG Laser or Plasma Spray
1 other identifier
interventional
24
1 country
1
Brief Summary
The attachment of peri implant soft tissue to the implant serves as a biological seal that can prevent the development of inflammatory peri-implant diseases. Presence of contaminants has been suggested to be associated with tissue damaging inflammation and titanium wear microparticles were demonstrated to activate osteoclastic action. Er: YAG laser has been extensively investigated clinically for applications for treating periimplantitis either independently or in combination with other techniques, showing favorable outcomes. Plasma spray treatment can decontaminate surfaces without modifying their topography. It is also able to increase the surface energy by obtaining more hydrophilic surfaces, which may increase the capacity of the titanium oxide layer to interact with cells and proteins of surrounding tissue improving cell adhesion to the treated surface.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at below P25 for not_applicable
Started Jun 2021
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
June 20, 2021
CompletedPrimary Completion
Last participant's last visit for primary outcome
June 13, 2022
CompletedStudy Completion
Last participant's last visit for all outcomes
September 22, 2022
CompletedFirst Submitted
Initial submission to the registry
March 5, 2023
CompletedFirst Posted
Study publicly available on registry
April 6, 2023
CompletedApril 6, 2023
April 1, 2023
12 months
March 5, 2023
April 4, 2023
Conditions
Keywords
Outcome Measures
Primary Outcomes (2)
histological assessment measuring inflammatory cells count.
sections of biopsies from peri-implant soft tissue stained with hematoxylin and eosin stain. H\&E stain was used for measuring inflammatory cells count and Masson's Trichrome stains for measuring collagen fibers area fraction.
two weeks after stage two surgery
histological assessment measuring collagen fibers area fraction.
sections of biopsies from peri-implant soft tissue stained with Masson trichrome stain.
two weeks after stage two surgery
Secondary Outcomes (3)
scanning electron microscopic analysis
two weeks after stage two surgery
clinical assessment measuring plaque index
two weeks after stage two surgery and after three months
clinical assessment measuring gingival index
two weeks after stage two surgery and after three months
Study Arms (3)
laser group
ACTIVE COMPARATORHealing abutments have been treated by Er:YAG laser. The laser-machine (with a wavelength of 2.940 nm) was used with settings of 100 mJ/pulse (12.7 J/cm₂) and 10 Hz. The healing abutments' surface was thoroughly decontaminated by the fiber tip in a semicircular contact mode with copious water irrigation.
plasma group
ACTIVE COMPARATORHealing abutments have been sprayed with an atmospheric pressure plasma device (Piezobrush® PZ2) , by using active gas, low-temperature plasma treatment under irradiation at 0.2 MPa for a total of 80 seconds at 10 mm (20 seconds per each surface)
control group
NO INTERVENTIONHealing abutments were installed as they came from industry and received no further treatment.
Interventions
Eligibility Criteria
You may qualify if:
- Male and female patients with age range from 20 to 45 years old.
- Patients need placement of fixed implant-supported prosthesis in maxillary arch.
- Patients who are medically free from any systemic diseases as evidenced by the health questionnaire, using modified Cornell medical index (Pendleton et al., 2004).
- patients with good oral hygiene (Plaque Index and bleeding on probing less than or equal to grade 1).
- Absence of any local conditions affecting bone-implant osseointegration (e.g., infection and poor bone density).
- The presence of sufficient bone width and height that permit the placement of implant with minimum diameter 3.5 mm and 8.5 mm length.
You may not qualify if:
- Presence of acute infections.
- Smokers.
- Pregnancy and lactation.
- Patients with a history of bisphosphonates therapy.
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
Ain Shams University -Faculty of dentistry
Cairo, 1156, Egypt
MeSH Terms
Interventions
Intervention Hierarchy (Ancestors)
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- RANDOMIZED
- Masking
- SINGLE
- Who Masked
- OUTCOMES ASSESSOR
- Masking Details
- assessor of clinical parameters, histological samples and scanning electron microscopy samples
- Purpose
- TREATMENT
- Intervention Model
- PARALLEL
- Sponsor Type
- OTHER
- Responsible Party
- PRINCIPAL INVESTIGATOR
- PI Title
- Assistant lecturer of oral medicine and periodontology
Study Record Dates
First Submitted
March 5, 2023
First Posted
April 6, 2023
Study Start
June 20, 2021
Primary Completion
June 13, 2022
Study Completion
September 22, 2022
Last Updated
April 6, 2023
Record last verified: 2023-04
Data Sharing
- IPD Sharing
- Will not share